6505--Metolazone Tablets (VA-26-00032237)

The solicitation requires offerors to submit a fully compliant subcontracting plan in accordance with Public Law 95‑507, FAR 52.219‑9, and VAAR 852.219‑70 for contracts exceeding $900,000. Offerors must justify any proposed subcontracting goals that are lower than the VA‑suggested goal or lower than the prior year’s achievement, detail the methods used to identify potential sources (including specific websites, organizations, and events), and indicate whether indirect costs are included in the dollar and percentage goals. A currently approved commercial plan (company‑wide or division‑wide) or a new plan must be provided, with separate dollar and percentage goals for each option period, and must reflect total projected subcontracting spend (including all indirect costs except those expressly excluded by FAR 52.219‑9(g)). The award is a small‑business set‑aside (HubZone, Service‑Disabled Veteran‑Owned, Women‑Owned, etc.) under NAICS [unspecified] with a base period and a five‑year option. Offerors must identify the exact manufacturing, sterilization, active pharmaceutical ingredient, packaging, and packing facilities (including FEI numbers and point‑of‑contact information) and provide evidence of API and final manufacturing processes that demonstrate substantial transformation, as required by VA’s country‑of‑origin guidance. The solicitation is issued as an RFQ/IFB, rated under DPAS, and includes standard FAR clauses (52.212‑1, ‑4, ‑5, etc.). All responses must be submitted in English, signed, and include the required forms and attachments, with any questions directed to the listed Contracting Officer.

Notice ID

bb1f760ea36047c3aaa4e32b226e04de

Solicitation Number

36E79726R0016

NAICS Code

325412

Classification Code

6505